Search

everythinglearnresearchcommunity

for

Search:↓

Hair analysis can track past cortisol levels in Cushing's Syndrome patients.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Stem cells in hair follicles are diverse and change throughout the hair cycle.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Blocking TGFβ-RI signaling enhances surface ectoderm differentiation from human stem cells.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Skin treatment can lower life quality for patients with skin conditions.

Hair casts on the scalp may be a sign of ongoing pemphigus vulgaris and could suggest a need to adjust treatment.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Standardizing and engineering organoids can improve their use in medicine and drug testing.